Tirzepatide, FDA-approved, targets GLP-1 and GIP receptors
Participants in Phase 2 trials reported the injection process to be generally well tolerated
If you are taking a related licensed medicine such as semaglutide (Ozempic or Wegovy) or tirzepatide (Mounjaro), which act on overlapping receptor pathways and are experiencing nausea, it is entirely appropriate to discuss this with your GP or prescriber
A simple strategy: at every meal, eat your protein source first, before anything else
Common adverse effects associated with probiotic use are typically mild and gastrointestinal in nature: Bloating and gas, especially during the first few days of use Abdominal discomfort or cramping Changes in bowel habits (diarrhea or constipation) Nausea (less common) These symptoms usually resolve within one to two weeks as the gut microbiome adjusts
It does not constitute medical advice and should not replace consultation with a qualified healthcare provider